LIGAND PHARMACEUTICALS INCORPORATED Income Taxes Receivable, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Income Taxes Receivable, Current of $2.91 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › and Others
us-gaap:IncomeTaxesReceivable · last filed 2026-08-07
- 2026-06-30: Income Taxes Receivable, Current $2.91M.
- 2026-03-31: Income Taxes Receivable, Current $1.42M.
- 2025-12-31: Income Taxes Receivable, Current $1.45M.
- 2025-09-30: Income Taxes Receivable, Current $536.00K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $2.91M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.42M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.45M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $536.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $828.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.34M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.07M 10-K · filed 2026-02-27 |
| 2024-09-30 | $7.81M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-12-31 | $6.39M 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 |
| 2022-12-31 | $4.61M 10-K · filed 2024-02-29 |
| 2022-09-30 | $785.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $964.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $6.19M 10-K · filed 2023-02-28 |
| 2021-09-30 | $6.38M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.69M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $1.15M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.22M 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $2.68M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $7.27M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $11.36M 10-K · filed 2021-02-24 |
| 2018-12-31 | $142.00K 10-K · filed 2020-02-27 |
| 2011-06-30 | $0.00 10-Q/A · filed 2012-02-10 |
| 2010-12-31 | $4.58M 10-K/A · filed 2012-11-14 |